The most common use of<unk>  is failed back surgery syndrome (FBSS) in the United States and peripheral ischemic pain in Europe. As of 2014 the FDA had approved<unk>  as a treatment for FBSS, chronic pain, Complex Regional Pain Syndrome, intractable angina, as well as visceral abdominal and perineal pain and pain in the extremities from nerve damage. Once a person has had a psychological evaluation and deemed an appropriate candidate for<unk> , a temporary implant is placed, called a trial, to determine the best stimulation pattern, and the person is sent home for three to ten days with an external pulse generator. If pain control and increased activity was achieved, a permanent system, with leads and a pulse generator, is placed.
Spinal cord stimulator
Thalamic stimulator
Non-invasive cerebellar stimulation
Baroreflex activation therapy
Cortical stimulation mapping
Retrobulbar block
Neuroreflexotherapy
Brain mapping